LIVN LivaNova PLC

LIVN financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1639691 Exchange: Nasdaq SIC: 3845 (Electromedical & Electrotherapeutic Apparatus) Latest filing: 10-Q filed Aug 5, 2026 Data checked: Oct 21, 2026
Showing 3 of 12 annual and 0 of 44 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$2.50B (Jun 2025)
Industry (SIC)
3845 Electromedical & Electrotherapeutic Apparatus
Incorporated
X0
Fiscal Year End
December (1231)
Phone
4402033250660
EIN
981268150
Headquarters
GLOUCESTER
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: Sand Holdco Plc (2015–2015)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$1.47B
Net Income
$188.55M
Total Assets
$2.64B
Total Equity
$1.33B
Total Debt
$293.49M
Free Cash Flow
$148.31M
Ratios
Gross Margin
68.1%
Operating Margin
12.7%
Net Margin
12.8%
Return on Equity
14.2%
Return on Assets
7.1%
Current Ratio
1.45x
Debt / Equity
0.22x
FCF / Assets
5.6%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

LivaNova PLC generated $1.39B of revenue in fiscal 2025, with net loss of $242.47M and an operating cash inflow of $254.34M. The $1.39B revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Revenue was 10.7% above fiscal 2024 revenue of $1.25B, marking a year-over-year increase. On a per-share basis, diluted EPS was -$4.45, which connects the reported earnings outcome with the company’s diluted share count. Against diluted EPS of $1.16 in fiscal 2024, the current result was 483.6% lower. Revenue equaled 0.53x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

After reported cost of revenue, the company retained $939.87M as gross profit before recognizing operating expenses and other items. The gross-profit relationship equaled 67.7% of revenue, quantifying the portion retained before operating expenses were recognized. The reported operating result was $199.39M, capturing profitability after direct costs and the operating expenses reflected in the statements. The operating result equaled 14.4% of revenue, placing the absolute operating-income figure in the context of the company’s sales base. The bottom-line result was a net loss of $242.47M after operating, financing, tax, and other recognized items. Net margin was -17.5%, reflecting a loss equal to 17.5% of reported revenue. Before income taxes, the company recorded a loss of $220.78M, bridging the operating result to the final net loss. Pretax margin was -15.9%, reflecting a pre-tax loss equal to 15.9% of revenue. The company recognized $21.64M of income tax for the period, completing the transition from pretax income to net income. The net loss equaled 20.2% of period-end equity, showing the deficit relative to book capital. Relative to total assets, the net loss represented 9.3%.

Liquidity and Capital Structure

At period end, the $2.61B asset base was financed through $1.41B of liabilities and $1.20B of equity. Current assets were $1.10B against $808.07M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. Current assets covered current liabilities by 1.36x, leaving a positive buffer for near-term obligations. The company held $635.55M in cash and equivalents, a narrower liquidity measure than total current assets. Measured only with cash and equivalents, coverage of current liabilities was 78.7%, excluding receivables and other current assets. The company carried $376.66M of total debt at period end, which frames its leverage and debt-service burden. The debt-to-equity relationship was 0.31x, showing how much debt the company carried for each unit of book equity. The debt-to-assets relationship was 14.5%, comparing borrowing with the total asset balance. The liabilities-to-assets relationship was 54.0%, placing reported obligations against the full positive asset balance. The cash-to-assets relationship was 24.4%, comparing reported cash and equivalents with the full positive asset balance. Compared with $2.51B in fiscal 2024, the current asset base moved 4.0% and finished higher. Book equity was 9.1% lower than fiscal 2024 equity of $1.32B, showing how shareholder capital changed year over year.

Cash Flow and Earnings Quality

The company reported $254.34M of operating cash flow, a cash inflow that shows the cash generated by operations. Capital spending was $81.05M, absorbing part of the cash generated from operations before free cash flow. Capital spending absorbed 31.9% of operating cash flow, quantifying the share of cash from operations directed to investment. Free cash flow came to $173.29M, leaving a positive amount after capital expenditures. Free cash flow represented 12.5% of revenue, linking post-investment cash generation with the company’s operating scale. Measured against total assets, free cash flow represented 6.6%, showing the cash productivity of the company’s assets.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for LivaNova PLC
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $1.39B $1.25B $1.15B
Cost of Revenue $448.18M $399.95M $397.73M
Gross Profit $939.87M $853.48M $755.82M
OPERATING EXPENSES
R&D Expense $185.76M $182.51M $193.82M
SG&A Expense $548.81M $508.88M $502.70M
Other Operating Expenses (derived) $5.90M $33.04M $127.80M
Operating Income $199.39M $129.05M $-68.50M
NON-OPERATING INCOME / EXPENSE
Interest Expense - - $58.85M
Interest Income $18.98M $30.08M $22.01M
Other Income/Expense $664.00K $1.10M $609.00K
Pretax Income $-220.78M $88.31M $-81.23M
Income Tax $21.64M $25.06M $-98.88M
Net Income $-242.47M $63.23M $17.55M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-4.45 $1.16 $0.32
Diluted Shares 54.55M 54.57M 54.21M
EBITDA $227.95M $154.16M $-43.76M
Depreciation & Amortization $28.56M $25.10M $24.74M
Balance Sheet
ASSETS
Cash & Equivalents $635.55M $428.86M $266.50M
Accounts Receivable $215.99M $193.16M $215.07M
Inventory $164.70M $147.57M $147.89M
Other Current Assets $36.77M $32.36M $27.18M
Current Assets $1.10B $1.13B $988.16M
PP&E (Net) $242.60M $170.26M $154.18M
Goodwill $792.84M $750.01M $782.94M
Intangible Assets $229.96M $237.29M $261.18M
Other Noncurrent Assets $15.69M $14.13M $12.06M
Noncurrent Assets $1.50B $1.38B $1.44B
Total Assets $2.61B $2.51B $2.43B
LIABILITIES
Accounts Payable $97.16M $69.73M $80.85M
Short-term Debt $31.47M $78.00M $18.11M
Other Current Liabilities $26.99M $33.46M $24.45M
Current Liabilities $808.07M $392.13M $334.98M
Long-term Debt $345.19M $549.62M $568.54M
Other Noncurrent Liabilities $55.37M $44.48M $47.73M
Noncurrent Liabilities $597.99M $794.01M $816.95M
Total Liabilities $1.41B $1.19B $1.15B
EQUITY
Common Stock $84.56M $83.16M $82.53M
Additional Paid-in Capital $2.25B $2.22B $2.19B
Retained Earnings $-1.15B $-903.25M $-966.48M
Accumulated OCI $7.33M $-80.17M $-27.88M
Total Equity $1.20B $1.32B $1.28B
Total Liabilities & Equity $2.61B $2.51B $2.43B
SUPPLEMENTAL
Total Debt $376.66M $627.63M $586.65M
Shares Outstanding 54.65M 54.35M 53.92M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $254.34M $183.04M $74.91M
Capital Expenditures $81.05M $47.11M $34.98M
Cash from Investing $-72.91M $-48.16M $-40.33M
Cash from Financing $-285.66M $18.55M $21.48M
Free Cash Flow $173.29M $135.93M $39.93M
Beginning Cash (CFS) $723.56M $577.87M $515.62M
Net Change in Cash $-104.23M $153.43M $56.07M
Effect of FX on Cash $16.23M $-7.75M $6.19M
Calculated Ending Cash $635.55M $723.56M $577.87M
Cash per BS $635.55M $428.86M $266.50M
Cash scope difference (CFS − BS) - $294.70M $311.37M
Cash per CFS $635.55M $723.56M $577.87M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is LivaNova PLC's annual revenue?

LivaNova PLC reported $1.47B in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is LivaNova PLC profitable?

Yes. LivaNova PLC reported $188.55M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

What is LivaNova PLC's debt level?

LivaNova PLC carries $293.49M in total debt as of trailing twelve months. Total shareholders' equity stands at $1.33B.

Does LivaNova PLC generate free cash flow?

Yes. Free cash flow was $148.31M for trailing twelve months. Operating cash flow was $249.26M.